TY  - JOUR
AU  - Sánchez-Ortega, Miriam
AU  - Garrido, Antonio
AU  - Sanz, Lorena
AU  - Torres-Pérez, Rafael
AU  - Hernandez, Carmen
AU  - Tsao, Ming Sound
AU  - Carrera, Ana Clara
AU  - Gutiérrez Uzquiza, Álvaro
PY  - 2025
DO  - 10.1186/s12943-025-02401-y
UR  - https://hdl.handle.net/20.500.14352/133157
T2  - Molecular Cancer
AB  - Lung squamous cell cancer (LUSC) is associated with very poor survival due to the lack of specific treatments. A common genetic alteration in LUSC involves mutations in (protein named NRF2) or its regulator, , resulting in increased activity of the...
LA  - eng
M2  - 197
PB  - Springer
KW  - CRISPRa/dCas9
KW  - LUSC treatment; NRF2
KW  - PI3Kα
KW  - TRIM24
TI  - Double vulnerability of active-NRF2 lung squamous cell carcinoma to NRF2 and TRIM24
TY  - journal article
VL  - 24
ER  -